Table 1.
Characteristics of coronaviruses that infect humans
Coronavirus | Date discovered | Dated diverged from common ancestor | Class/ genera | Symptoms | Transmission | Incubation period (days) | Risk Factors |
---|---|---|---|---|---|---|---|
HCoV-229E |
1966, Chicago |
1800s [6] |
Alpha |
Common cold symptoms: rhinorrhoea, nasal congestion, sore throat, headache and chills [7]. Occurrences of lower respiratory tract infection (LRTI) mainly in children [8] |
Respiratory |
2-4 [7] |
Immunocompromised, children, elderly. |
HCoV-OC43 |
1967 |
1850-1900 [9] |
Beta |
Common cold symptoms. Higher rates of LRTI in adults than HCoV-229E [10] |
Respiratory |
2-4 [7] |
Immunocompromised, children, elderly. |
SARS-CoV |
2002, Guangdong |
1985-1998 [9] |
Beta |
Fever, dry cough, headache, dizziness, rhinorrhoea, myalgia, chills, rigors, diarrhoea, vomiting. LRTI, acute respiratory distress syndrome (ARDS), shock, multi-organ failure [11] |
Mainly Respiratory. Faeces-oral, to a lesser extent [12] |
2-7 [13] |
Advanced age, male sex [14]. No recorded deaths in children and teenagers [11]. |
HCoV-NL63 |
2004, Netherlands |
1200s [9] |
Alpha |
Common cold symptoms [7], LRTI [15] |
Respiratory |
2-4 [7] |
Immunocompromised, children, elderly. |
HCoV-HKU1 |
2005, Hong Kong |
1950s [9] |
Beta |
Common cold symptoms [7], diarrhoea, vomiting [16], childhood febrile seizures [17] |
Respiratory |
2-4 [7] |
Immunocompromised, children, elderly, smoking, inhaled corticosteroids [16]. |
MERS-CoV |
2012, Saudi Arabia |
2006 [9] |
Beta |
Fever, chills, cough, myalgia and gastrointestinal symptoms LRTI, ARDS, multi-organ failure, renal failure [18] |
Respiratory. Requires close and prolonged contact [19] |
2-14 [20] |
Advanced age, male sex, chronic conditions (present in 75% of patients) such as diabetes, obesity, hypertension, lung conditions, cardiac conditions [18,21]. |
SARS-CoV-2 | 2019 | Not known | Beta | Fever, dry cough, dyspnoea, myalgia and fatigue [22]. Less gastrointestinal involvement than SARS and MERS [23] | Primarily respiratory droplets. To a lesser extent: faecal-ran and through eyes [24]. Airborne transmission during aerosol generating procedures. Airborne transmission in indoor settings with poor ventilation under investigation [25] | 5-6 d on average. Up to 14 d [25] | Advanced age, male sex. Co-morbidities (present in 20%-51% of patients): hypertension, diabetes, cardiovascular disease, pulmonary disease and malignancy [26]. |